3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors

By Fu Ying   Sun Yi-Na   Yi Ke-Han   Li Ming-Qiang   Cao Hai-Feng   Li Jia-Zhong   Ye Fei  

Molecules, Vol. 22, Iss. 6, 2017-06 ,pp. : 959-959

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite

Computational Identification of the Paralogs and Orthologs of Human Cytochrome P450 Superfamily and the Implication in Drug Discovery

By Pan Shu-Ting   Xue Danfeng   Li Zhi-Ling   Zhou Zhi-Wei   He Zhi-Xu   Yang Yinxue   Yang Tianxin   Qiu Jia-Xuan   Zhou Shu-Feng  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1020-1020

MDPI

Access to resources Recommend Favorite

Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics

By Chhabra Saurabh  

Pharmaceuticals, Vol. 10, Iss. 2, 2017-04 ,pp. : 40-40

MDPI

Access to resources Recommend Favorite

Combined 3D-QSAR, Molecular Docking and Molecular Dynamics Study on Derivatives of Peptide Epoxyketone and Tyropeptin-Boronic Acid as Inhibitors Against the β5 Subunit of Human 20S Proteasome

By Liu Jianling   Zhang Hong   Xiao Zhengtao   Wang Fangfang   Wang Xia   Wang Yonghua  

International Journal of Molecular Sciences, Vol. 12, Iss. 3, 2011-03 ,pp. : 1807-1835

MDPI

Access to resources Recommend Favorite